Distribution of TDP-43 Pathology in Hippocampal Synaptic Relays Suggests Transsynaptic Propagation in Frontotemporal Lobar Degeneration.


Journal

Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 30 05 2019
revised: 23 09 2019
pubmed: 11 5 2020
medline: 28 11 2020
entrez: 11 5 2020
Statut: ppublish

Résumé

Hyperphosphorylation, nuclear depletion, and aggregation of TDP-43 in ubiquitinated inclusions is a hallmark of frontotemporal lobar degeneration (FTLD-TDP). Evidence of potential spread of TDP-43 along synaptic connections in the human is largely limited to qualitative and semiquantitative observations. We quantitatively investigated potential transsynaptic propagation of TDP-43 across the well-established chain of single synaptic connections of the hippocampus. Hippocampi from 5 participants with clinical diagnoses of primary progressive aphasia and 2 participants with behavioral variant frontotemporal dementia, all with postmortem diagnoses of FTLD-TDP, were examined. TDP-43-positive mature (darkly stained) and pre-inclusions (diffuse puncta or fibrillar staining) in the granule cell layer of dentate gyrus (DG) and pyramidal cell layers of Cornu Ammonis (CA)3, CA2, and CA1 were quantified using unbiased stereology. The density of mature TDP-43 inclusions was higher in the DG than in the CA fields (p < 0.05). There were no differences in inclusion densities across the CA fields. TDP-43 pre-inclusions densities were not different across the 4 subregions. There was significantly higher preinclusion density than mature inclusions in CA3, but not in other subregions. Analysis of normalized total counts in place of densities revealed virtually identical results. Our finding of greatest mature inclusion deposition in the DG, coupled with more preinclusions than mature inclusions at the next relay station (CA3), and reduced densities of both in CA2-CA1, provide evidence in support of a sequential transsynaptic propagation mechanism of TDP-43 aggregates.

Identifiants

pubmed: 32388566
pii: 5835531
doi: 10.1093/jnen/nlaa029
pmc: PMC7241939
doi:

Substances chimiques

DNA-Binding Proteins 0
TARDBP protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

585-591

Subventions

Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC008552
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG020506
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062566
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085770
Pays : United States

Informations de copyright

© 2020 American Association of Neuropathologists, Inc. All rights reserved.

Références

J Cell Biol. 2015 Nov 23;211(4):897-911
pubmed: 26598621
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Acta Neuropathol. 2014 Mar;127(3):423-439
pubmed: 24407427
Dement Neuropsychol. 2013 Jan-Mar;7(1):19-26
pubmed: 29213815
Neurobiol Aging. 2015 Nov;36(11):3108-3115
pubmed: 26329689
Acta Neuropathol. 2007 Jul;114(1):5-22
pubmed: 17579875
Neuropathol Appl Neurobiol. 2015 Aug;41(5):578-97
pubmed: 25487060
Acta Neuropathol. 2007 Jul;114(1):63-70
pubmed: 17492294
J Neuropathol Exp Neurol. 1998 Jan;57(1):63-75
pubmed: 9600198
J Neuropathol Exp Neurol. 2019 Mar 1;78(3):229-237
pubmed: 30753613
J Comp Neurol. 2003 Jan 6;455(2):249-59
pubmed: 12454989
J Biol Chem. 2011 May 27;286(21):18664-72
pubmed: 21454603
Brain Res. 2012 Jun 26;1462:61-80
pubmed: 22445064
PLoS One. 2012;7(2):e31302
pubmed: 22312444
Prion. 2011 Jan-Mar;5(1):1-5
pubmed: 21135580
Dement Neuropsychol. 2013 Jan 1;7(1):2-9
pubmed: 24707349
Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11
pubmed: 17084815
Ann Neurol. 2018 Jun;83(6):1096-1104
pubmed: 29665116
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1206-9
pubmed: 12933919
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
J Neurol Neurosurg Psychiatry. 2016 May;87(5):501-11
pubmed: 26216940
Nat Neurosci. 2012 Jun 26;15(7):936-9
pubmed: 22735515
Neurology. 2016 Feb 16;86(7):627-36
pubmed: 26791154
Nat Rev Neurosci. 2011 Nov 30;13(1):38-50
pubmed: 22127299
Acta Neuropathol. 2008 Aug;116(2):193-203
pubmed: 18560845
Ann Neurol. 1982 Jun;11(6):592-8
pubmed: 7114808
Acta Neuropathol. 2006 Nov;112(5):539-49
pubmed: 17021754
Neuron. 2012 Feb 23;73(4):685-97
pubmed: 22365544
Neuropathol Appl Neurobiol. 2012 Feb;38(1):25-38
pubmed: 21696412
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Neurology. 2018 Jan 30;90(5):e396-e403
pubmed: 29305438
Nat Rev Neurol. 2014 Nov;10(11):661-70
pubmed: 25311585

Auteurs

Pouya Jamshidi (P)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Garam Kim (G)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Ryan K Shahidehpour (RK)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Kabriya Bolbolan (K)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Tamar Gefen (T)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Eileen H Bigio (EH)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Marek-Marsel Mesulam (MM)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Changiz Geula (C)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH